In a study published in Cell Stem Cell, scientists tested retinal pigment epithelial stem cells in a phase 1/2a clinical trial. The cells were obtained from adult postmortem eye tissue. These early-stage trials are designed to determine whether a treatment can be safely administered.
Related Posts
India Faces Meta-Crisis of Air Pollution, Chronic Diseases, Women’s Health Gaps: Prof. Reddy
Post Views: 22 Prof. Reddy highlighted a stark health equity…
HIV jab for 115 nations rests on Indian regulators
Post Views: 34 In 2015, the apex committee of the…
Coimbatore Hosts India’s First Inter‑Hospital Liver Transplant Swap
Post Views: 238 In a medical milestone, surgeons in Coimbatore…